FIBROGEN INC — Director's Dealing 2023

Sep 2, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2023-08-30

Reporting Person: Chung Christine (SVP, China Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-08-30	Common Stock	A	120000	$0.00	Acquired	356327	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-08-30	Stock Option (Right to Buy)	$1.21	A	220000	Acquired	2033-08-29	Common Stock (220000)	Direct

Footnotes

F1: Represents the grant of restricted stock units (RSUs) that vest quarterly over one year from September 6, 2023.

F2: Twenty-five percent of the shares subject to the option will vest on August 30, 2024, and the remainder of the options will vest in equal amounts quarterly thereafter for the following three years.